The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
While long COVID is slowly becoming more understood, ordinary COVID-19 patients are experiencing lasting effects - scientists discovered that 76% of people have atleast one recurring symptom, six months after the original illness.
Asymptomatic testing will be made available to all local authorities across England this week after research revealed 1 in 3 people have coronavirus without showing symptoms.
The approval of the Moderna COVID vaccine in the UK comes 2 days after European medical regulators, but not a moment too soon - the death toll continues to climb, standing at 78,508 currently.
The team at Rush University Medical Center have conducted the first US investigation into opioid use and pancreatic cancer - how could this change prescriptions?
Katharine Jenner, Campaign Director and Mhairi Brown, Policy and Public Affairs Manager of Action on Sugar and Action on Salt debate who should be responsible for tackling the biggest cause of premature death and disability in the UK when Public Health England is dissolved.
Two divisions of Active Care Group – Christchurch Group and Remeo – discuss the importance of infection prevention and control in the healthcare sector in light of COVID-19.
Open Access Government takes a look at the ways in which Olivier Véran, the French Minister for Health and Solidarity, has supported French citizens through a health crisis and beyond.
Jane C Khoury & Shelley R Ehrlich from Division of Biostatistics and Epidemiology, Cincinnati Children’s Hospital Medical Center, highlight the consequences of foetal development in a “sweet” uterus – including the short- and long-term transgenerational outcomes.
